Menu
Search
|

Menu

Close
X

Agilent Technologies Inc A.N (New York Stock Exchange)

64.99 USD
+0.27 (+0.42%)
As of Nov 16
chart
Previous Close 64.72
Open 64.38
Volume 784,215
3m Avg Volume 558,390
Today’s High 65.55
Today’s Low 64.38
52 Week High 75.00
52 Week Low 60.46
Shares Outstanding (mil) 321.83
Market Capitalization (mil) 21,356.51
Forward P/E 34.21
Dividend (Yield %) 0.13 ( 0.80 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.71 Mean rating from 14 analysts

KEY STATS

Revenue (mm, USD)
FY18
3,620
FY17
4,472
FY16
4,202
FY15
4,038
EPS (USD)
FY18
2.017
FY17
2.095
FY16
1.403
FY15
1.317
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
34.21
33.59
Price to Sales (TTM)
vs sector
4.86
5.69
Price to Book (MRQ)
vs sector
4.64
5.11
Price to Cash Flow (TTM)
vs sector
25.15
23.52
Total Debt to Equity (MRQ)
vs sector
45.16
15.71
LT Debt to Equity (MRQ)
vs sector
39.08
11.53
Return on Investment (TTM)
vs sector
9.31
15.05
Return on Equity (TTM)
vs sector
14.14
16.62

EXECUTIVE LEADERSHIP

Boon Hwee Koh
Independent Chairman of the Board, Since 2017
Salary: --
Bonus: --
Michael McMullen
President, Chief Executive Officer, Director, Since 2015
Salary: $1,095,830.00
Bonus: --
Robert McMahon
Chief Financial Officer, Senior Vice President, Since 2018
Salary: --
Bonus: --
Jacob Thaysen
President of Agilent's Life Sciences and Applied Markets Group, Since 2018
Salary: $495,000.00
Bonus: --
Michael Tang
Senior Vice President, General Counsel, Secretary, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

5301 Stevens Creek Blvd
SANTA CLARA   CA   95051-7201

Phone: +1408.3458886

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

SPONSORED STORIES